[go: up one dir, main page]

GB2195893B - Sustained release pharmaceutical compositions - Google Patents

Sustained release pharmaceutical compositions

Info

Publication number
GB2195893B
GB2195893B GB8723515A GB8723515A GB2195893B GB 2195893 B GB2195893 B GB 2195893B GB 8723515 A GB8723515 A GB 8723515A GB 8723515 A GB8723515 A GB 8723515A GB 2195893 B GB2195893 B GB 2195893B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
sustained release
release pharmaceutical
sustained
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8723515A
Other versions
GB8723515D0 (en
GB2195893A (en
Inventor
Henry C Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8723515D0 publication Critical patent/GB8723515D0/en
Publication of GB2195893A publication Critical patent/GB2195893A/en
Application granted granted Critical
Publication of GB2195893B publication Critical patent/GB2195893B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB8723515A 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions Expired - Lifetime GB2195893B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (3)

Publication Number Publication Date
GB8723515D0 GB8723515D0 (en) 1987-11-11
GB2195893A GB2195893A (en) 1988-04-20
GB2195893B true GB2195893B (en) 1991-05-08

Family

ID=10605478

Family Applications (2)

Application Number Title Priority Date Filing Date
GB868624213A Pending GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions
GB8723515A Expired - Lifetime GB2195893B (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB868624213A Pending GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Country Status (24)

Country Link
JP (1) JPS63101334A (en)
KR (1) KR880004801A (en)
AU (1) AU7942087A (en)
BE (1) BE1000732A5 (en)
CA (1) CA1332809C (en)
CH (1) CH675831A5 (en)
DE (1) DE3733540A1 (en)
DK (1) DK527487A (en)
ES (1) ES2014518A6 (en)
FI (1) FI874414A7 (en)
FR (1) FR2604902B1 (en)
GB (2) GB8624213D0 (en)
GR (1) GR871550B (en)
HU (1) HU201875B (en)
IL (1) IL84104A0 (en)
IT (1) IT1221493B (en)
LU (1) LU87009A1 (en)
NL (1) NL8702294A (en)
NO (1) NO874200L (en)
NZ (1) NZ222083A (en)
PH (1) PH24227A (en)
PT (1) PT85880B (en)
SE (1) SE8703889L (en)
ZA (1) ZA877617B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
EE05022B1 (en) * 1999-03-31 2008-06-16 Janssen Pharmaceutica N.V. Use of Pregelatinised Starch in a Hydrophilic Controlled Release Preparation and a Hydrophilic Controlled Release Preparation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102886D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
DE602004022205D1 (en) * 2004-09-09 2009-09-03 Psicofarma S A De C V PHARMACEUTICAL COMPOSITION FOR THE DELAYED RELEASE OF HYDRALAZINE AND ITS USE AS A SUPPORT FOR CANCER THERAPY

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390311A (en) * 1972-02-22 1975-04-09 Lilly Co Eli Timed-release pharmaceutical preparations
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (en) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen ORAL RETARDED ACETYLSALICYL ACID FORMULATIONS

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390311A (en) * 1972-02-22 1975-04-09 Lilly Co Eli Timed-release pharmaceutical preparations
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
EP0156592A2 (en) * 1984-03-21 1985-10-02 American Home Products Corporation Substained release pharmaceutical capsules
GB2157169A (en) * 1984-03-21 1985-10-23 American Home Prod Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
IT1221493B (en) 1990-07-06
CH675831A5 (en) 1990-11-15
DE3733540A1 (en) 1988-04-14
IL84104A0 (en) 1988-03-31
FR2604902B1 (en) 1991-04-26
SE8703889L (en) 1988-04-10
GB8723515D0 (en) 1987-11-11
PH24227A (en) 1990-05-04
IT8748469A0 (en) 1987-10-08
NL8702294A (en) 1988-05-02
PT85880B (en) 1990-07-31
GR871550B (en) 1988-02-15
JPS63101334A (en) 1988-05-06
DK527487D0 (en) 1987-10-08
NO874200D0 (en) 1987-10-07
ZA877617B (en) 1989-05-30
SE8703889D0 (en) 1987-10-08
ES2014518A6 (en) 1990-07-16
BE1000732A5 (en) 1989-03-21
HUT52958A (en) 1990-09-28
NZ222083A (en) 1991-05-28
CA1332809C (en) 1994-11-01
LU87009A1 (en) 1988-05-03
KR880004801A (en) 1988-06-27
FI874414A0 (en) 1987-10-07
GB8624213D0 (en) 1986-11-12
FI874414L (en) 1988-04-10
GB2195893A (en) 1988-04-20
PT85880A (en) 1987-11-01
FR2604902A1 (en) 1988-04-15
HU201875B (en) 1991-01-28
NO874200L (en) 1988-04-11
DK527487A (en) 1988-04-10
FI874414A7 (en) 1988-04-10
AU7942087A (en) 1988-04-14

Similar Documents

Publication Publication Date Title
GB2230185B (en) Sustained release pharmaceutical compositions
GB2196964B (en) Pharmaceutical compositions
AR243378A1 (en) Sustained release pharmaceutical composition
GB8716301D0 (en) Pharmaceutical compositions
GB8723121D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8708587D0 (en) Pharmaceutical compositions
IL82924A0 (en) Sustained release pharmaceutical compositions containing katotifen
GB8717581D0 (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB8629781D0 (en) Pharmaceutical compositions
ZA904925B (en) Sustained release pharmaceutical compositions
GB2195893B (en) Sustained release pharmaceutical compositions
GB8723120D0 (en) Pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GB8620073D0 (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GR871999B (en) Pharmaceutical compositions
GB8624214D0 (en) Sustained release pharmaceutical compositions
GB8413797D0 (en) Sustained release pharmaceutical compositions
GB8413796D0 (en) Sustained release pharmaceutical compositions
GB8616695D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee